as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹159.17
Change
-3.81 (-2.34%)
Open
₹158.67
Prev. Close
₹162.98
Day High
₹160.6
Day Low
₹158.0
Volume Analysis
Traded
6,740,091
Delivered
3,568,196
Delivery %
52.94%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹163.12 | ₹161.86 | ₹160.52 | ₹159.26 | ₹157.92 | ₹156.66 | ₹155.32 |
| Fibonacci | ₹161.86 | ₹160.87 | ₹160.25 | ₹159.26 | ₹158.27 | ₹157.65 | ₹156.66 |
| Camarilla | ₹159.89 | ₹159.65 | ₹159.41 | ₹159.26 | ₹158.93 | ₹158.69 | ₹158.46 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
-29.24%
1 Week
-10.98%
1 Month
-21.81%
3 Months
-34.46%
6 Months
-39.64%
1 Year
+3.12%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc - Icicisilve lands in the middle of the pack on TopFund's composite fundamentals check, at 51/100. The strongest factor is Liquidity (83/100), while Risk & Volatility (24/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
51/100 — AverageData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Icicisilve?
Frequently Asked Questions about Icicipramc - Icicisilve
Icicipramc - Icicisilve (SILVERIETF) closed at ₹159.17 on NSE on 19 November 2026, down 3.81 (2.34%) from the previous close.
Icicipramc - Icicisilve trades on the NSE (National Stock Exchange of India) under the symbol SILVERIETF.
Icicipramc - Icicisilve has a TopFund Quality Score of 51/100 (Average), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Icicisilve?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.